Clinical Trial Detail

NCT ID NCT02666105
Title Exemestane in Post-Menopausal Women With NSCLC
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

lung non-small cell carcinoma

Therapies

Exemestane

Age Groups: adult

No variant requirements are available.